Join to View Full Profile
1101 Madison StSte 1400Seattle, WA 98104
Phone+1 206-386-6266
Fax+1 206-622-1052
Dr. Porter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. James Porter Jr. is a Seattle-based urologist with subspecialties in minimally invasive surgery, stone disease, and surgical oncology. He graduated from The University of Toledo College of Medicine in 1990 and completed his residency in urology at the University of Washington in 1996. He is an Associate Professor at UW Medicine/University of Washington Medical Center and currently serves as Chief Medical Officer at Medtronic, Inc. His clinical expertise includes minimally invasive urologic procedures like lymphadenectomy, robotic prostatectomy, and nephrectomy. Dr. Porter has numerous publications, including recent studies on urologic oncology and robotic surgery, and is involved in several clinical trials. He has received the Menon Medal for Robotic Surgery and multiple CMS Meaningful Use Certifications.
Education & Training
University of WashingtonResidency, Urology, 1990 - 1996
The University of Toledo College of MedicineClass of 1990
Ohio State UnivBs, Biochemistry, 1980 - 1984
Certifications & Licensure
OR State Medical License 2012 - Present
WA State Medical License 1992 - 2026
NV State Medical License 2017 - 2022
LA State Medical License 2013 - 2013
American Board of Urology Urology
Awards, Honors, & Recognition
- Menon Medal for Robotic Surgery NARUS, 2023
- CMS Meaningful Use Stage 2 Certification ezAccess Patient Portal, Medical Office Technologies, Inc., 2012-2017
- CMS Meaningful Use Stage 2 Certification Centricity Practice Solution, GE Healthcare, 2012-2017
Clinical Trials
- SurgiQuest AirSeal in Robotic Partial Nephrectomy - (TARPAN Study) Start of enrollment: 2014 Oct 01
- Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer Start of enrollment: 2018 Mar 20
- Staple vs. Suture in Robotic Prostatectomy Start of enrollment: 2015 Mar 01
Publications & Presentations
PubMed
- Impact of ischaemia duration and clamping strategy in patients with solitary kidney undergoing partial nephrectomy.Francesco Cei, Daniele Cignoli, Irene Franco, Koon Ho Rha, Christian Wagner
BJU International. 2026-03-01 - Elevated creatinine-to-hemoglobin ratio is a novel preoperative marker for worsened survival outcomes in upper tract urothelial carcinoma: analysis from the ROBUUST re...Margaret F Meagher, Clara Cerrato, Mimi V Nguyen, Riccardo Autorino, Reza Mehrazin
Minerva Urology and Nephrology. 2025-12-01 - 1 citationsPrimary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumour.Luca Antonelli, Axel Heidenreich, Aditya Bagrodia, Armon Amini, Fady Baky
BJU International. 2025-04-01
Journal Articles
- Society of Robotic Surgery Review: Recommendations Regarding the Risk of COVID-19 Transmission During Minimally Invasive SurgeryJames Porter, Elliot Blau et al., British Journal of Urology, 5/8/2020
Press Mentions
Medtronic Announces U.S. IDE Clinical Study Evaluating Hugo™ Robotic-Assisted Surgery SystemOctober 8th, 2025- Medtronic Expand URO U.S. Clinical Trial Meets Safety and Effectiveness Primary Endpoints for Hugo™ Robotic-Assisted Surgery SystemApril 27th, 2025
- How Can Robotic Telesurgery Advance?April 17th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
